Statistics

Total Visits

Views
Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program42

File Visits

Downloads
335.pdf9

Select a period of time:

Number of views in the range

Views
Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program40

Number of downloads in the range

Downloads
335.pdf9

Views

Views
October 20258
November 20256
December 202514
January 20262
February 20260
March 202610
April 20260
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • October 2025
    2
  • November 2025
    0
  • December 2025
    3
  • January 2026
    0
  • February 2026
    0
  • March 2026
    4
  • April 2026
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States22
Brazil7
Argentina4
Angola2
Ecuador1
United Kingdom1
Mexico1
Uruguay1
Venezuela1
 

Top countries by downloads

Downloads
United States6
Brazil1
 

Top cities views

Views
San Jose2
Aparecida de Goiânia1
Berazategui1
Brusque1
Caruaru1
Divinópolis1
Formosa1
García1
Guayaquil1
Ilhabela1
 

Top cities by downloads

Downloads